CWG
EVOK

C WorldWide Group’s Evoke Pharma EVOK Stock Holding History

C WorldWide Group’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-313
Closed -$318K – 132
2015
Q1 		$318K Hold
313
– – ﹤0.01% 112
2014
Q4 		$266K Hold
313
– – ﹤0.01% 109
2014
Q3 		$250K Buy
+313
New +$302K ﹤0.01% 105

Other funds holding EVOK

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FANJ
Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

C WorldWide Group's EVOK Position: Q2 2015 in Review

C WorldWide Group sold out of Evoke Pharma (EVOK) in Q2 2015, closing a stake of 313 shares — an estimated $318K sold.

C WorldWide Group first reported a position in EVOK in Q3 2014 and held it in 3 quarters. The position peaked at $318K in Q1 2015. 12 funds tracked by Wall St. Rank hold EVOK as of Q2 2015.

  • C WorldWide Group reported no remaining Evoke Pharma position as of Q2 2015 after selling out during the quarter.
  • C WorldWide Group sold 313 Evoke Pharma shares in Q2 2015, an estimated $318K.
  • C WorldWide Group first reported a position in Evoke Pharma in Q3 2014 and held it in 3 quarters.
  • C WorldWide Group's Evoke Pharma position peaked at $318K in Q1 2015.
  • 12 funds tracked by Wall St. Rank held Evoke Pharma as of Q2 2015.

Based on C WorldWide Group's 13F filing for Q2 2015, filed 21 Jul 2015.